Cognition Disorders Completed Phase 2 Trials for Ziprasidone (DB00246)

Also known as: Cognitive Disorder / Cognitive Disorders / Cognition Disorder / Cognitive Dysfunction / Cognitive Dysfunctions / Cognitive disorder (disorder)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096863The MIND Study: Modifying the INcidence of DeliriumTreatment